Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
2018 · Annals of Oncology · 557 citations
https://doi.org/10.1093/annonc/mdy218